MedPath

The Relationship Between Adipokines, Obesity and Insulin Resistance in Women With Polycystic Ovarian Syndrome

Completed
Conditions
Polycystic Ovarian Syndrome
Registration Number
NCT02869750
Lead Sponsor
Ain Shams University
Brief Summary

To evaluate possible clinical effects of adipokines , ( ghrelin, resistin and adiponectin), in obese and non-obese patients with polycystic ovary syndrome (PCOS).

Detailed Description

Seventy selected PCOS patients will be recruited for this study, and will be divided into two groups based on their body mass index (BMI): 35 obese (BMI≥ 25 kg/m2, group A), 35 non-obese (BMI\<25 kg/m2, group B). In addition, 35 healthy non-obese women (BMI\<25 kg/m2) will bw enrolled as the control (group C). Serum levels of FSH (follicle stimulating hormone), LH (luteinizing hormone), T(testosterone), glucose, insulin, adiponectin, resistin and resistin will bw detected, and compared the differences of them among three groups

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
300
Inclusion Criteria
  • Females with PCOS in child bearing age who presented at reproductive and endocrinology clinics at Ain Shams University Maternity Hospital
Exclusion Criteria
  • Known androgen secreting tumor.
  • PCO on ovarian stimulation medications
  • PCO with any other medical illness.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
serum ghrelin level24 hours

measuring ghrelin, and ) in the three groups

serum resistin level24 hours

serum resistin level in the three groups

serum adiponectin level24 hours

serum adiponectin level in the three groups

Secondary Outcome Measures
NameTimeMethod
serum testosterone level24 hours after labor

serum testosterone level in three groups

Glucose/Insulin ratio24 hours

fasting glucose and insulin in three groups

Trial Locations

Locations (1)

Ahmed Kotb

🇪🇬

Cairo, Al Qahirah, Egypt

© Copyright 2025. All Rights Reserved by MedPath